 |
 |
 |
|
Population Pharmacokinetics of Sofosbuvir and Its Major Metabolite (GS-331007)
in Healthy and HCV-Infected Adult Subjects
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Brian Kirby,1 Toufigh Gordi,2 William T. Symonds,1 Brian P. Kearney,1 Anita Mathias1
1Gilead Sciences, Inc., Foster City, CA; 2Rosa & Co. LLC, San Carlos, CA






|
|
|
 |
 |
|
|